119 related articles for article (PubMed ID: 9481500)
1. Stunned thyroid after a diagnostic dose of I-131 for a whole body scan.
Kao CH
Clin Nucl Med; 1998 Feb; 23(2):102-4. PubMed ID: 9481500
[No Abstract] [Full Text] [Related]
2. Thyroid Remnant Estimation by Diagnostic Dose (131)I Scintigraphy or (99m)TcO4(-) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131)I Imaging.
Liu G; Li N; Li X; Chen S; Du B; Li Y
Biomed Res Int; 2016; 2016():4763824. PubMed ID: 27034938
[TBL] [Abstract][Full Text] [Related]
3. Stunned thyroid after high-dose I-131 imaging.
Park HM
Clin Nucl Med; 1992 Jun; 17(6):501-2. PubMed ID: 1617848
[No Abstract] [Full Text] [Related]
4. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
Kalinyak JE; McDougall IR
Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
[No Abstract] [Full Text] [Related]
5. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
Yagcloglu H; Ozalp E; Ibis E; Aras G
Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
[No Abstract] [Full Text] [Related]
6. Thyroid stunning after (131)I diagnostic whole-body scanning.
McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
[No Abstract] [Full Text] [Related]
7. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
Rosário PW; Barroso AL; Purisch S
Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
[No Abstract] [Full Text] [Related]
8. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
[TBL] [Abstract][Full Text] [Related]
9. Do we read carefully?
Medvedec M
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
[No Abstract] [Full Text] [Related]
10. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
11. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa).
Gonzalez ME; Muttikkal TJ; Rehm PK
J Radiol Case Rep; 2015 Jun; 9(6):44-9. PubMed ID: 26622936
[TBL] [Abstract][Full Text] [Related]
12. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
[TBL] [Abstract][Full Text] [Related]
13. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
[TBL] [Abstract][Full Text] [Related]
14. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
McDougall IR
Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
[No Abstract] [Full Text] [Related]
15. Thyroid stunning.
Medvedec M
J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
[No Abstract] [Full Text] [Related]
16. Iodine 131 total body scan--extrathyroidal uptake of radioiodine.
Wu SY; Brown T; Milne N; Egbert R; Kabok A; Lyons KP; Hickey J
Semin Nucl Med; 1986 Jan; 16(1):82-4. PubMed ID: 3945830
[No Abstract] [Full Text] [Related]
17. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
Lees W; Mansberg R; Roberts J; Towson J; Chua E; Turtle J
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1421-7. PubMed ID: 12397458
[TBL] [Abstract][Full Text] [Related]
18. Delayed radioiodine organification in Plummer's disease.
Intenzo CM; Park CH; Kim SM
Clin Nucl Med; 1995 Mar; 20(3):203-5. PubMed ID: 7750210
[TBL] [Abstract][Full Text] [Related]
19. [Importance of scintigraphy in the evaluation of surgical treatment outcome in differentiated cancer of the thyroid gland].
Protsyk VS; Shishkina VV; Chebotareva ED; Siniuta BF; Dzhuzha DA; Sagan DL
Klin Khir; 1997; (9-10):29-32. PubMed ID: 9511322
[TBL] [Abstract][Full Text] [Related]
20. Stunning after tracer dosimetry.
Diehl M; Grünwald F
J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
[No Abstract] [Full Text] [Related]
[Next] [New Search]